申请人:Merck Sharp & Dohme Corp.
公开号:US20170015633A1
公开(公告)日:2017-01-19
Disclosed are pyrimidine carboxamide compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2), pharmaceutical compositions and uses thereof.